Author:
Omran Heymut,Kunde-Trommer Jutta,Blank Rainer
Reference66 articles.
1. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics;Bagni;J Clin Invest,2012
2. Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial;Berry-Kravis;J Child Adolesc Psychopharmacol,2006
3. Psychopharmacology in fragile X syndrome – present and future;Berry-Kravis;Ment Retard Dev Disabil Res Rev,2004
4. Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome;Berry-Kravis;J Dev Behav Pediatr,2008
5. Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status;Blehaut;PLoS One,2010